학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,503건 | 목록 1~20
Academic Journal
Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation - An Official Journal of the International Society of Quality of Life Research. 34(11):3191-3204
Academic Journal
Till A; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. andreas.till@bfarm.de.; Siddiqui RA; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Altbürger C; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM) Heidelberg, Heidelberg, Germany.; Schwarz R; National Association of Statutory Health Insurance Funds, GKV-Spitzenverband, Berlin, Germany.; Huebner T; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Wolf J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Andres D; Federal Ministry of Health, Bonn, Germany.; Anker A; Federal Ministry of Health, Bonn, Germany.; Aretz S; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.; Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.; European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS), Bonn, Germany.; Haack TB; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tubingen, Germany.; Center for Rare Diseases, University of Tübingen, Tubingen, Germany.; Berlage T; Fraunhofer Institute for Applied Information Technology FIT, Sankt Augustin, Germany.; RWTH Aachen University, Aachen, Germany.; Beule D; Berlin Institute of Health, Translational Research Unit of Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg (a partnership between DKFZ and Medical Center-University of Freiburg), Freiburg, Germany.; Buchhalter I; Omics IT and Data Management Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bussmann J; German Association of Academic Medical Centers (Verband der Universitätsklinika Deutschlands), Berlin, Germany.; Engel C; Institute for Medical Informatics, Statistics and Epidemiology, Leipzig University, Leipzig, Germany.; Friedrichs J; House of Cancer Self-Help - Federal Association, Bonn, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg (a partnership between DKFZ and Heidelberg University Hospital), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Haenisch B; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Center for Translational Medicine, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.; Hahne A; BRCA Network-Help for People affected by Hereditary Cancer, Bonn, Germany.; Hübschmann D; National Center for Tumor Diseases (NCT), NCT Heidelberg (a partnership between DKFZ and Heidelberg University Hospital), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; BRCA Network-Help for People affected by Hereditary Cancer, Bonn, Germany.; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; von Kessel F; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Klatt R; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg (a partnership between DKFZ and Heidelberg University Hospital), Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.; Kron A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Krude H; Institute of Experimental Pediatric Endocrinology, Charite-Universitätsmedizin, Berlin, Germany.; Lübbe A; Robert Koch Institute, Berlin, Germany.; Lührig U; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Malek N; Department for Internal Medicine 1, M3-Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tubingen, Germany.; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany.; Mertes C; TUM School of Computation, Information and Technology, Technical University of Munich, Garching, Germany.; Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany.; Möller Y; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tubingen, Germany.; Mundlos C; Alliance for Chronic Rare Diseases Germany (ACHSE), DRK Klinikum Berlin Mitte, Berlin, Germany.; Nöthen MM; Institute of Human Genetics, University Hospital Bonn, Bonn, Germany.; Ossowski S; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tubingen, Germany.; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tubingen, Germany.; Pötschke L; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Rasokat A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University Hospital of Cologne, Cologne, Germany.; National Network Genomic Medicine (nNGM) Lung Cancer, University Hospital of Cologne, Cologne, Germany.; Riess O; Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tubingen, Germany.; Center for Rare Diseases, University of Tübingen, Tubingen, Germany.; Schade S; Federal Ministry of Health, Bonn, Germany.; Schirmacher P; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM) Heidelberg, Heidelberg, Germany.; Schmutzler R; Faculty of Medicine, University of Cologne and Center for Familial Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.; German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC), University Hospital of Cologne, Cologne, Germany.; Scholl C; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.; Semler SC; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Spielmann M; Institute of Human Genetics, University Hospital Schleswig-Holstein, University of Lübeck and Kiel University, Lubeck, Germany.; Stegle O; Division of Computational Genomics & Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; European Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.; Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Center for Personalized Medicine (ZPM) Heidelberg, Heidelberg, Germany.; Straßburger J; Federal Ministry of Health, Bonn, Germany.; Schröck E; Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden, University of Technology and Faculty of Medicine of TUD Dresden University of Technology, Dresden, Germany.; Krawczak M; Technology, Methods, and Infrastructure for Networked Medical Research (TMF), Berlin, Germany.; Institute of Medical Informatics and Statistics, Kiel University, University Medical Center Schleswig-Holstein, Kiel, Germany.; Kohlbacher O; Center for Personalized Medicine Tübingen, University Hospital Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.; Department of Computer Science, University of Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.; Institute for Translational Bioinformatics, University Hospital Tübingen, Tubingen, Germany. oliver.kohlbacher@uni-tuebingen.de.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process
Academic Journal
Seidl CI; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, Mainz 55131, Germany.; Zhao B; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Gao X; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Berger R; Physics at Interfaces, Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz 55128, Germany.; Jian L; Physics at Interfaces, Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz 55128, Germany.; Koynov K; Physics at Interfaces, Max Planck Institute for Polymer Research, Ackermannweg 10, Mainz 55128, Germany.; Gangluff M; Department Chemie, Johannes Gutenberg University Mainz, Duesbergweg 10-14, Mainz 55131, Germany.; BioNTech SE, An der Goldgrube 12, Mainz 55131, Germany.; Fontijn R; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Su L; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Bussmann J; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Zhang H; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Barz M; Leiden Academic Center for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstraße 1, Mainz 55131, Germany.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-8252 (Electronic) Linking ISSN: 19448244 NLM ISO Abbreviation: ACS Appl Mater Interfaces Subsets: MEDLINE
Academic Journal
IEEE Transactions on Neural Systems and Rehabilitation Engineering IEEE Trans. Neural Syst. Rehabil. Eng. Neural Systems and Rehabilitation Engineering, IEEE Transactions on. 16(5):479-484 Oct, 2008
검색 결과 제한하기
제한된 항목
[검색어] Bussmann, J B
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어